These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17134006)

  • 21. The favourable effect of cyclophosphamide in myasthenia gravis.
    Nouza K; Smat V
    Rev Fr Etud Clin Biol; 1968 Feb; 13(2):161-3. PubMed ID: 5654288
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of the thymus in the pathogenesis of myasthenia gravis.
    Onodera H
    Tohoku J Exp Med; 2005 Oct; 207(2):87-98. PubMed ID: 16141677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Juvenile myasthenia gravis].
    Ohno K; Sahashi K
    Ryoikibetsu Shokogun Shirizu; 2001; (36):340-3. PubMed ID: 11596404
    [No Abstract]   [Full Text] [Related]  

  • 24. [Letter: Vitiligo, thymus defect and autoimmunity--a hypothetical pathogenesis].
    Thivolet J; Ortonne JP; Monier JC; Perrot H
    Hautarzt; 1975 Jan; 26(1):50-1. PubMed ID: 1116946
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapeutic options in autoimmune myasthenia gravis.
    García-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Riebeling C; Cervera R
    Autoimmun Rev; 2007 Jun; 6(6):373-8. PubMed ID: 17537383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis.
    Ponseti JM; Gamez J; Vilallonga R; Ruiz C; Azem J; López-Cano M; Armengol M
    Eur J Cardiothorac Surg; 2008 Nov; 34(5):1062-7. PubMed ID: 18760934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marked sensitivity to pancuronium in a patient without clinical manifestations of myasthenia gravis.
    Enoki T; Naito Y; Hirokawa Y; Nomura R; Hatano Y; Mori K
    Anesth Analg; 1989 Dec; 69(6):840-2. PubMed ID: 2589664
    [No Abstract]   [Full Text] [Related]  

  • 28. [Myasthenia gravis].
    Suzumura A
    Ryoikibetsu Shokogun Shirizu; 2000; (31):20-3. PubMed ID: 11269057
    [No Abstract]   [Full Text] [Related]  

  • 29. Thymectomy: a potential therapeutic method for autoimmune diseases besides myasthenia gravis.
    Guo W; Zhao YP; Jiang YG; Fan SZ; Wang RW; Li ZP
    Med Hypotheses; 2008; 70(5):1072-3. PubMed ID: 18155855
    [No Abstract]   [Full Text] [Related]  

  • 30. [Thymus surgery in myasthenia gravis].
    Scheld HH; Mulch J; Hehrlein FW
    Med Welt; 1981 Apr; 32(17):645-8. PubMed ID: 7219164
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical characteristics and managements of juvenile myasthenia gravis].
    Ishigaki K
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():533-8. PubMed ID: 26480755
    [No Abstract]   [Full Text] [Related]  

  • 32. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular Myasthenia Gravis treatment: the case against prednisone therapy and thymectomy.
    Gilbert ME; De Sousa EA; Savino PJ
    Arch Neurol; 2007 Dec; 64(12):1790-2. PubMed ID: 18071047
    [No Abstract]   [Full Text] [Related]  

  • 34. A history of treatments for myasthenia gravis.
    Keesey JC
    Semin Neurol; 2004 Mar; 24(1):5-16. PubMed ID: 15229787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Disorder of thymic regulatory function in immune processes and the approaches to its correction].
    Koval'chuk LV; Aleĭnikova NV; Chermeneva LM; Arion VIa; Dishkant IP
    Zh Obshch Biol; 1981; 42(5):751-61. PubMed ID: 7027678
    [No Abstract]   [Full Text] [Related]  

  • 36. The thymus. Pediatric surgical aspects.
    Midulla PS; Dolgin SE; Shlasko E
    Chest Surg Clin N Am; 2001 May; 11(2):255-67. PubMed ID: 11413755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppressive or surgical treatment for ocular Myasthenia Gravis.
    Chavis PS; Stickler DE; Walker A
    Arch Neurol; 2007 Dec; 64(12):1792-4. PubMed ID: 18071048
    [No Abstract]   [Full Text] [Related]  

  • 38. [Nicotinic cholinergic receptor and myasthenia gravis].
    Tu LH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1983 Aug; 16(4):250-3. PubMed ID: 6315322
    [No Abstract]   [Full Text] [Related]  

  • 39. Treating ocular Myasthenia Gravis with inadequate evidence.
    Roach ES
    Arch Neurol; 2007 Dec; 64(12):1794-5. PubMed ID: 18071049
    [No Abstract]   [Full Text] [Related]  

  • 40. Ocular myasthenia gravis.
    Gilbert ME; Savino PJ
    Int Ophthalmol Clin; 2007; 47(4):93-103, ix. PubMed ID: 18049283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.